SCHEMBL25037518

SCHEMBL25037518

CC(C)(C)CCc1ccc(OC2=CCCC=C2)cc1

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26026900 0.85 ESR1 (0.38)
SCHEMBL25039155 0.83 ALDH1A1 (0.38)
SCHEMBL7561099 0.77 FFAR1 (0.41)
SCHEMBL19346893 0.76 RAB9A (0.46) HRH3
SCHEMBL13019820 0.74 TEAD4 (0.41)
SCHEMBL8348295 0.71 MAOA (0.41)
SCHEMBL21540141 0.71 LTA4H (0.46)
SCHEMBL18726479 0.71 ESR2 (0.48)
SCHEMBL12153390 0.71 ALDH1A1 (0.48)
SCHEMBL2600047 0.71 FFAR1 (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4134076-A1 THERAPY FOR INHIBITION OF SINGLE-STRANDED RNA VIRUS REPLICATION Redhill Biopharma Ltd. (IL) 2023-02-15 EP disclosed